Research Study Summary
Have You Been Diagnosed with Systemic Lupus Erythematosus-SLE? Research Study DV7-SLE-02
Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent.
If you have SLE, you may be eligible to participate in this important clinical research study. You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required.
Compensation for time and travel up to $1,375.00. This is a phase 1 study requiring multiple injections, blood draws, assessments and visits to the site.
To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.
Patient Inclusion Criteria:
You may qualify to participate if you:
- Are at least 18 years old
- Have a confirmed diagnosis of Systemic Lupus Erythematosus
Patient Exclusion Criteria:
- If you do not have a confirmed diagnosis of Systemic Lupus Erythematosus.
To Learn more
Date Last Changed:
July 18, 2013